Compound antihypertensive preparation

A compound preparation and high blood pressure technology, applied in the field of medicine, can solve the problems of affecting the curative effect of drugs, inaccurate clinical drug dosage, increased side effects, etc., and achieve the effects of improving the curative effect of blood pressure, less adverse reactions and good blood pressure effect.

Inactive Publication Date: 2010-06-30
JIANGSU JIBEIER PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] The product of the present invention overcomes that when felodipine and telmisartan are used clinically, the drug dose is increased to ensure the curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound antihypertensive preparation
  • Compound antihypertensive preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A compound preparation containing the following components:

[0034] Felodipine 5mg

[0035] Telmisartan 80mg

[0036] Starch 10mg

[0037] Calcium sulfate 4mg

[0038] Talc 1mg

[0039] In this embodiment, the compound felodipine-telmisartan tablet can be made, and the preparation method can adopt the preparation method of ordinary pharmaceutical preparations.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound preparation for treating hypertension, which comprises 1-10mg of felodipine and 10-100mg of telmisartan. The product of the invention overcomes the defect that a side effect is markedly enhanced caused by increasing the medicament dosage for ensuring the curative effect when the felodipine and the telmisartan are clinically used at present and one medicament is singly used, and provides a new compound preparation. The felodipine and the telmisartan are combined, and the curative effect has synergistic and complementary actions; the tolerance of patients is increased, the compliance is improved, the dosage is decreased, an adverse reaction is lightened, and the compound preparation is convenient to take and has low price.

Description

Technical field [0001] The invention relates to the technical field of medicine and discloses a compound antihypertensive preparation. Background technique [0002] Hypertension is the most common cardiovascular disease and a major public health problem worldwide. There are currently about 100 million hypertensive patients in my country. The results of an epidemiological survey in 1991 showed that the awareness rate of hypertension in my country's urban and rural areas was 36% and 13%, and the treatment rate was 17% and 5%, respectively. The form of hypertension prevention and treatment is quite severe. According to WTO forecasts, non-communicable diseases will account for 79% of deaths in my country by 2020, and cardiovascular diseases will take the first place. [0003] Commonly used drugs for the treatment of hypertension are the calcium antagonist felodipine and the angiotensin receptor antagonist telmisartan. [0004] Felodipine (Felodipine), chemical name 4-(2,3-dichlorophen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4422A61K31/4184A61P9/12
Inventor 吴修艮陈进高瑞银魏福荣朱月华
Owner JIANGSU JIBEIER PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap